Key result
A dual chamber pacemaker with atrial dynamic overdrive and sotalol effectively reduced paroxysmal atrial fibrillation to only 4 short-term episodes over 3 months in a patient with bradycardia-tachycardia syndrome.
Why the study?
Does a dual chamber pacemaker with atrial dynamic overdrive reduce paroxysmal atrial fibrillation in a patient with bradycardia-tachycardia syndrome?
Case Report (n=1)
Does a dual chamber pacemaker with atrial dynamic overdrive reduce paroxysmal atrial fibrillation in a patient with bradycardia-tachycardia syndrome?
A dual chamber pacemaker with atrial dynamic overdrive and sotalol successfully suppressed frequent paroxysmal atrial fibrillation in a patient with bradycardia-tachycardia syndrome.
May support combined overdrive pacing and sotalol in refractory bradycardia-tachycardia syndrome; hypothesis-generating, should not yet change practice.
BACKGROUND: Atrial fibrillation is the most frequent cardiac dysrhythmia. The aim of this study was to show the role and the efficacy of a dual chamber pacemaker with the algorithm of atrial dynamic overdrive, in the suppression of paroxysmal atrial fibrillation. CASE REPORT: A woman with a classical bradycardia-tachycardia syndrome, and frequent attacks of atrial fibrillation, underwent the implantation of a single chamber permanent pacemaker (WI). Pacemaker successfully treated the episodes of symptomatic bradycardia, but the patient had frequent attacks of atrial fibrillation, despite the use of different antiarrhythmic drugs, which she did not tolerate well. The decision was made to reimplant a permanent dual chamber pacemaker with the algorithm of atrial dynamic overdrive. The pacemaker was programmed to the basic rate of 75/min, while rate at rest was 55/min. In addition, sotalol was administered. After three months, the patient became asymptomatic with only 4 short-term episodes of atrial fibrillation, and a high level of atrial pacing (99%). CONCLUSION: In selected patients with bradycardia-tachycardia syndrome, atrial-based pacing seemed to be very effective in reducing the incidence of paroxysmal atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Radjen et al. (2005) conducted a case report in Paroxysmal atrial fibrillation and bradycardia-tachycardia syndrome (n=1). Dual chamber pacemaker with atrial dynamic overdrive algorithm and sotalol vs. Single chamber permanent pacemaker (VVI) and previous antiarrhythmic drugs was evaluated on Suppression of paroxysmal atrial fibrillation. A dual chamber pacemaker with atrial dynamic overdrive and sotalol effectively reduced paroxysmal atrial fibrillation to only 4 short-term episodes over 3 months in a patient with bradycardia-tachycardia syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: